New blood score aims to catch deadly liver cancer sooner
NCT ID NCT07319299
Summary
This study is testing a new blood test score, called the GAAD score, to see if it can help detect liver cancer (hepatocellular carcinoma) earlier in people at high risk. It will enroll 2,100 adults with chronic liver disease or cirrhosis who are already getting regular cancer screening. Researchers will compare how well the new GAAD score works compared to current standard tests like ultrasound and a blood protein called AFP.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine Siriraj Hospital
Bangkoknoi, Bangkok, 10700, Thailand
Conditions
Explore the condition pages connected to this study.